Acquisition Opportunity Hartley Medical recently became part of Pentec Health, indicating a new ownership and strategic direction. This change may open cross-sell opportunities for Pentec Health’s broader pharma services, distribution networks, and infusion therapy capabilities to accelerate post-merger integration.

National Expansion Readiness With existing national reach in infusion therapy and 400+ physician and institution partners, Hartley Medical has a scalable platform that can be leveraged to expand sales of sterile compounded injectables, compliance and quality systems, and related services to additional pain management and hospital networks.

Growth and Scale Estimated revenue in the 10 to 25 million range and a workforce of 11-50 suggests agility with room for increased contract manufacturing capacity, potentially benefiting from expanded production lines, enhanced cold chain, and expanded distribution to attract larger health systems.

Tech & Digital Outreach A tech stack spanning AWS, Webflow, WordPress, and Shopify indicates modern digital channels for lead generation, e-commerce-like ordering for institutional clients, and scalable customer onboarding. This enables targeted digital campaigns to growing pain management networks.

Competitive Positioning As a national leader in intra-spinal therapy compounding with prestigious California roots, Hartley Medical can emphasize stability, regulatory compliance, and clinical credibility to compete with larger distributors. This positioning supports upsell of high‑value sterile compounding and infusion services to risk-averse hospitals and pain clinics.